tert-Butyl 4-(3-nitrophenoxy)piperidine-1-carboxylate

Catalog No.: 
ACSCVC463
CAS No.: 
586412-88-6
Molecular Formula: 
C16H22N2O5
Molecular Weight: 
322.36
tert-Butyl 4-(3-nitrophenoxy)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$128.00InquiryInquiry
1g95%$411.00InquiryInquiry
5g95%$2014.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(3-nitrophenoxy)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(3-nitrophenoxy)piperidine-1-carboxylate
MDL No.MFCD16620911
Molecular FormulaC16H22N2O5
Molecular Weight322.36
SMILESO=C(N1CCC(OC2=CC=CC([N+]([O-])=O)=C2)CC1)OC(C)(C)C
InChI KeyAXAXKDMYYJZOKN-UHFFFAOYSA-N
Synonymtert-butyl 4-(3-nitrophenoxy)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(3-nitrophenoxy)-, 1,1-dimethylethyl ester
CAS No.586412-88-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSCVC463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSCVC463 route product structure diagram
    ACSCVC463586412-88-6
Inquiry

2. ACSCVC463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSCVC463 route product structure diagram
    ACSCVC463586412-88-6
Inquiry

3. ACSCVC463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSCVC463 route product structure diagram
    ACSCVC463586412-88-6
Inquiry

Comments (0)